With Theranos gone, Alere is looking more valuable as the last man standing in point of care.
I don't think they can buy shares in the open market while the merger agreement is in effect. That would be highly illegal.
I was tempted to add at 82 and change but passed .. How do you get comfortable with China's 1/3 contribution to sales & profits in a nation that might be at the peak of a capital spending cycle?
Anything coming out of Canada is a disaster. They know business like they know hot weather in winter.
hoping sub $100. There's a short thesis on valueinvestorsclub. Not sure what to make of it. Definitely some risks and a high valuation but at the right price I think it's one of the better names if you have to be in biotech.
You can never get stuck with a merger deal, but you usually must pay the termination fee. In this case $400 million.
I can't resist. Buffett and Endo in the same sentence! Buffett's #1 rule is invest in the right sector, in the right people, and in the right company. The idea that Buffett says you can be greedy when others are fearful will take you to the cleaners. The truth is the drug industry is a bad place to allocate your capital. Period. Don't put a penny in it and you'll be happier. Buffett was asked to invest in Giilead when it was a baby, before it hit what 80 billion? You know what he said: NO. That's discipline. Learn something.
Maybe amortization, but goodwill isn't an expense that's taken through the cash flow statement. If it's written down, you know they made a big mistake. I'm not sure how this works at this point, but if earning power is impaired by 30% as we saw Friday, will goodwill be written down sometime this year?
I saw a big red flag when Handler used the word 'indefatigable' in the annual letter last month. That's freaky. You can't mint success by being a clone of someone else. It's not even worth trying. Follow good habits yes but sounding intelligent is very different than being intelligent.
optimism mongering just as deadly as fear mongering. Fear mongering is safer though so I'll say that is a better position to be in.
Not really, BV is really quite irrelevant, not to mention Endo has negative equity. I do see $1/share in cash though. And $14 billion in flush from overpriced acquisitions. The debt is also real at 8 billion. If you can convince me they won't go bankrupt, that might be a starting point.
No worries, I have no problem with thoughtful analysis of why Endo might or might not be a buy, but brainless buying or selling is really just gambling.